Infliximab vs. Adalimumab for Crohn's disease.
Mulani
P
P
Chao
J
J
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D003362:Cost-Benefit Analysis; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069285:Infliximab; D000068879:Adalimumab